Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM.

Sidana S, Lin Y, Cowan AJ, Rodríguez-Otero P, Scheid C, Mueller PJ, Broussard C, Krengel P, Li Y, Piault R, Corrao A, Ho C, Patel K

Open source

DOI: 10.1182/bloodadvances.2025017186
Published: 2026 Jun 9
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025017186,
  title = {Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM.},
  author = {Sidana S and Lin Y and Cowan AJ and Rodríguez-Otero P and Scheid C and Mueller PJ and Broussard C and Krengel P and Li Y and Piault R and Corrao A and Ho C and Patel K},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2025017186},
  url = {https://doi.org/10.1182/bloodadvances.2025017186}
}

RIS

TY  - JOUR
TI  - Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM.
AU  - Sidana S
AU  - Lin Y
AU  - Cowan AJ
AU  - Rodríguez-Otero P
AU  - Scheid C
AU  - Mueller PJ
AU  - Broussard C
AU  - Krengel P
AU  - Li Y
AU  - Piault R
AU  - Corrao A
AU  - Ho C
AU  - Patel K
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2025017186
UR  - https://doi.org/10.1182/bloodadvances.2025017186
ER  -

APA

S, S., Y, L., AJ, C., P, R., C, S., PJ, M., C, B., P, K., Y, L., R, P., A, C., C, H., & K, P. (2026). Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM.. Blood advances. https://doi.org/10.1182/bloodadvances.2025017186

Source records

pubmed · retrieved 2026-09-26T20:25:40.385Z